within Pharmacolibrary.Drugs.ATC.D;

model D08AJ59
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dodeclonium bromide is a quaternary ammonium compound used primarily as an antiseptic and disinfectant. It is often found in topical preparations for skin disinfection and less commonly in veterinary use. The drug is not widely approved for human therapeutic use today and is mostly superseded by other agents.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or clinical pharmacokinetic parameter data are available for dodeclonium bromide or its combinations in any population or dosing route.</p><h4>References</h4><ol><li><p>Löscher, W, &amp; Klein, P (2021). The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. <i>CNS drugs</i> 35(9) 935–963. DOI:<a href=&quot;https://doi.org/10.1007/s40263-021-00827-8&quot;>10.1007/s40263-021-00827-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34145528/&quot;>https://pubmed.ncbi.nlm.nih.gov/34145528</a></p></li><li><p>Rony, F, et al., &amp; Klein, J (2024). Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant. <i>Pulmonary pharmacology &amp; therapeutics</i> 85 102299–None. DOI:<a href=&quot;https://doi.org/10.1016/j.pupt.2024.102299&quot;>10.1016/j.pupt.2024.102299</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38663512/&quot;>https://pubmed.ncbi.nlm.nih.gov/38663512</a></p></li><li><p>Mousavi, T, et al., &amp; Abdollahi, M (2023). Pharmacotherapy for gastric and intestinal cramping pain: ‎ current and emerging therapies. <i>Expert opinion on pharmacotherapy</i> 24(18) 2021–2033. DOI:<a href=&quot;https://doi.org/10.1080/14656566.2023.2265830&quot;>10.1080/14656566.2023.2265830</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37788098/&quot;>https://pubmed.ncbi.nlm.nih.gov/37788098</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D08AJ59;
